DTSS News & Events

Datasea Intelligent Technology announced that the company is advancing compliance work and related procedures required for U.S. Food and Drug Administration establishment registration and device listing for one of its acoustic brain-computer interface products. The Company has submitted its Dun & Bradstreet Data Universal Numbering System application, which is one of the administrative steps that support future FDA-related registration activities. The Company expects to continue evaluating and preparing for potential establishment registration, device listing and related regulatory procedures in accordance with applicable FDA requirements. These efforts represent an important preliminary step in the Company's international strategy for its acoustic medical and BCI-related product portfolio. The product is based on the Company's acoustic medical and BCI technology roadmap and integrates four core capabilities: acoustic stimulation, bone-conduction neuromodulation, EEG signal acquisition and AI-assisted health management. It is designed to focus on non-invasive acoustic neuromodulation-related application scenarios, with potential applications across neurological health fields, including brain health management, rehabilitation support, cognitive function monitoring, sleep quality optimization and emotional regulation. The Company believes that the integration of acoustic intervention, physiological signal monitoring and AI-based analysis provides a differentiated technical pathway compared with traditional invasive BCI approaches, and may offer potential advantages in safety profile, product accessibility, user compliance and future commercialization scalability.

Datasea announced continued progress in the international commercialization of its acoustic technology-enabled head-focused health and wellness care robot business, alongside preparations for the U.S. market launch of its acoustic disinfection product line. Building on previously disclosed developments, Datasea is advancing the commercialization of its wellness care robot solutions across China, broader international markets, and the United States through collaboration with strategic partners. In China, related products and services have been deployed in more than 50 cities across approximately 300 service locations. Internationally, the Company has established market cooperation in multiple Asian markets, including South Korea, Hong Kong SAR, Taiwan region, Singapore, Indonesia, and Malaysia. In the United States, Datasea has initiated early-stage commercial rollout activities, including pilot deployments and customer engagements in Boston, New Jersey, Los Angeles, and Phoenix. These developments reflect the Company's efforts to establish a scalable commercialization pathway for its acoustic technology-enabled wellness solutions across multiple geographic markets. In parallel, Datasea announced that its acoustic disinfection products, including its Smart Air Sterilizer, have completed overseas testing and certification procedures and are now preparing for commercial launch in the United States. As disclosed in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025, the Company plans to advance U.S. market sales of these products through Datasea Acoustics, its wholly owned Delaware subsidiary.

Datasea announced initial commercial rollout progress in the United States for its acoustic technology-enabled health and wellness care robot solutions, developed in collaboration with Yizhimei Technology. According to the Company's partners, customer signings have recently been secured and early-stage deployments have been initiated across multiple U.S. regions, including Boston, New Jersey, Los Angeles, and Phoenix, representing an early step in the Company's efforts to expand into the U.S. market. Building on its prior activities in China and other Asian markets, the Company is working with partners to explore the deployment of acoustic-technology-enabled solutions in additional healthcare and wellness settings. As previously disclosed, the Company has also been advancing initial customer deployments and market exploration in other international markets, including South Korea, Hong Kong SAR, Taiwan region, Singapore, Indonesia, and Malaysia. The Company believes these initial deployments are expected to cover multiple service locations and operational terminals, primarily within hospital-related environments, beauty service providers, and wellness centers. These developments represent an early step in Datasea's U.S. commercialization strategy and are expected to support the initial generation of service-related revenues in the U.S. market, while providing validation for the Company's scalable "technology + service + application scenario" business model. At this stage, Datasea primarily provides core acoustic technology, technical service support, and scenario-based solutions to empower partners in deploying acoustic technology-enabled wellness care robots across hospitals, beauty service settings, wellness centers, and other health service environments. Based on the Company's current cooperation structure, potential revenue streams associated with these deployments may include technical service fees, solution integration income, and recurring service-related revenues linked to deployed terminals, subject to ongoing commercialization progress.

Datasea announced continued progress in its collaboration with Yizhimei Technology Co. relating to technical services and commercial deployment of acoustic + AI head-care robots for health and wellness applications. Under the framework of the existing cooperation agreement, the company has achieved initial technical service revenue. In addition, the parties have further entered into an expanded cooperation arrangement to jointly advance the research and development of acoustic AI health care robots and accelerate market expansion. The upgraded collaboration marks a transition from an initial technology-enablement phase to a stage focused on product commercialization and broader industrial deployment.